Yacktman beat the market in 2018. In 2025, it’s a different story.
We analyzed 2,500 hedge funds — and found heavy selling across Big Tech.
The wild ride of Monish Pabrai’s 100% concentrated hedge fund.
You can’t buy into the Medallion Fund. But here’s what happens if you follow Renaissance Technologies stock picks.
Health Care, Coupang, and a whole lot of alpha. We dug into his portfolio and backtested 7 years of his top picks.
The billionaire just made fossil-fuel-free stocks his #1 target — with a $2.5B bet against ESG darlings. But he’s still betting on a few key names.
Meet the resource-heavy fund that thrives when the market panics.
We analyzed his latest 13F to see if it’s worth following his bold bets.
What Happens When You Copy a Billionaire’s Portfolio? We ran the numbers against the market.
Akre’s 10-year performance of 300% (!) is a masterclass in patience, concentration, and business-first investing.
He sold everything, bought puts on last quarter’s favorites, and left one lonely long. Here’s what it means (or doesn’t).
